President Donald Trump’s nominee to chair the Federal Reserve, Kevin Warsh, refused to confirm whether he has investments connected to Jeffrey Epstein during a Senate confirmation hearing on Tuesday.
Senator Elizabeth Warren, a Massachusetts Democrat, said Warsh has more than $100 million in investments that have not been disclosed to ethics officials or the public.
Warren asked, “Do the Juggernaut Fund or the THSDFS LLC invest in any companies affiliated with President Trump and his family, companies that have facilitated money laundering, Chinese-controlled companies or financing vehicles established by Jeffrey Epstein?”
“Let me first share a point of agreement with you,” Warsh responded. “The Fed has two tools. One is its monetary policy and the second is its credibility, and the scandals that you talked about, the ethics problems you’ve talked about, went to the core of the credibility that has hurt the Fed.”
Warren interjected to say she “appreciates” his answer but asked him to answer her question.
“Senator, I’ve worked tirelessly with the ethics officials at the Office of Government ethics. I’m doing ethics agreement with them, and have agreed, senator, to sell all of my financial assets,” Warsh said.
While Warsh answered, Warren said, “yes, and you have not revealed $100 million in assets,” and, “that’s not my question.”
“Mr. Warsh, are you refusing to tell us if you have investments in, for example, in vehicles set up to advance Jeffrey Epstein? Is that what you’re telling us? You just won’t tell us?” Warren said.
Warsh said the assets represented as Juggernaut will be sold if he is confirmed, before he takes office and signs the oath of office.
Warren, ranking member of the Senate Banking, Housing, and Urban Affairs Committee, sent a letter to Warsh last month requesting answers following reports that Warsh’s name appears in materials released by the Justice Department in response to the Epstein Files Transparency Act.
This is a breaking news story. Updates to follow.
Do you have a story that Newsweek should be covering? Do you have any questions about this story? Contact LiveNews@newsweek.com.
Read the full article here
